Cipla Limited is an Indian multinational pharmaceutical company, headquartered in Mumbai, India. Cipla primarily develops medicines to treat respiratory, cardiovascular disease, arthritis, diabetes, weight control and depression; other medical conditions. Read More
India Ratings and Research (Ind-Ra) said on Tuesday that 13.7 per cent y-o-y revenue growth in India's pharmaceutical market during 2021 was led by continued demand normalisation post the high growth months of April and May. ...
Even as the US giant drug maker Moderna's COVID-19 messenger RNA (mRNA) vaccine is expected to reach India this week, discussions are still going on over indemnity waiver, informed sources. ...
India Ratings and Research (Ind-Ra) has said the 14.1 per cent y-o-y growth in pharmaceutical market during June was led by a normalisation of demand post high growth months of April (51.5 per cent) and May (47.8 per cent). ...
US biotechnology company Moderna on Tuesday announced that India has granted permission for its COVID-19 vaccine to be imported into the country for restricted use in an emergency situation. ...
The Mumbai-based pharmaceutical multinational Cipla, on behalf of the US pharma major Moderna, has requested for import and marketing authorisation of its COVID-19 vaccines. ...
Roche India's Antibody Cocktail (Casirivimab and Imdevimab) is now available as a therapy to treat patients with mild and moderate COVID-19 infection at the Indraprastha Apollo Hospitals in Delhi, the hospital said in a statement on Friday. ...
American pharmaceutical giant Pfizer on Wednesday informs the Central government that its COVID-19 vaccine is suitable for all aged 12 and above and can be stored at 2-8 degrees for over a month, according to the sources. ...
